The U.S. Food and Drug Administration now says it's a priority to more quickly share information about faulty products within the medical community and with the public.
The agency is working with the University of Maryland and other institutions to develop an easily accessible system that will begin collecting and analyzing real-time data as soon as devices hit the market. The effort aims to not only help protect patients from harmful products but steer them to innovations showing unexpected or special benefits.
Read Full Article »